EXPOSURE VIA MUCOSA

EXPOSURE VIA MUCOSA was reported 60 times

EXPOSURE VIA MUCOSA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TETRACAINE 2 0.0051
1 NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE 1 0.0049
2 ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 1 0.0011
3 NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE 1 0.0009
4 MECHLORETHAMINE HYDROCHLORIDE 1 0.0004
5 BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 1 0.0003
6 FLUOROMETHOLONE 1 0.0003
7 CAPSAICIN 1 0.0003
8 AMIKACIN 5 0.0003
9 VIBEGRON 1 0.0001
10 CRISABOROLE 1 0.0001
11 ACETYLCYSTEINE 1 0.0001
12 MUPIROCIN CALCIUM 1 0.0001
13 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE 2 0.0001
14 AZELASTINE 1 0.0001
15 FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE 2 0.0000
16 SOMATROPIN 3 0.0000
17 LATANOPROST 2 0.0000
18 ETHYL ALCOHOL 1 0.0000
19 FLUTICASONE PROPIONATE NASAL 1 0.0000
20 EPINEPHRINE 2 0.0000
21 ISOPROPYL ALCOHOL 1 0.0000
22 ALBUTEROL SULFATE 8 0.0000
23 ALCOHOL 1 0.0000
24 AZITHROMYCIN MONOHYDRATE 1 0.0000
25 ESTRADIOL TRANSDERMAL 1 0.0000
26 CABOZANTINIB 1 0.0000
27 HYDROXYZINE 1 0.0000
28 TOPIRAMATE 1 0.0000
29 LORATADINE TABLET 1 0.0000
30 LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 1 0.0000
31 CONJUGATED ESTROGENS 1 0.0000
32 ESTROGENS, CONJUGATED 1 0.0000
33 AZITHROMYCIN DIHYDRATE 1 0.0000
34 LIDOCAINE HYDROCHLORIDE 1 0.0000
35 SULFASALAZINE 1 0.0000
36 DICLOFENAC SODIUM 2 0.0000
37 ORAL SEMAGLUTIDE 1 0.0000
38 ESTRADIOL 1 0.0000
39 TADALAFIL 1 0.0000
40 DUPILUMAB 5 0.0000
41 LORATADINE 1 0.0000
42 AMBRISENTAN 1 0.0000
43 WARFARIN 1 0.0000
44 TACROLIMUS OINTMENT 0.1% 1 0.0000
45 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
46 TREPROSTINIL 1 0.0000
47 FLUTICASONE PROPIONATE 1 0.0000
48 TACROLIMUS 1 0.0000
49 ADAPALENE 1 0.0000
50 LEVONORGESTREL 1 0.0000
51 ESOMEPRAZOLE MAGNESIUM 1 0.0000
52 GABAPENTIN 1 0.0000
53 LENALIDOMIDE 1 0.0000
54 ASPIRIN 1 0.0000